The Russian Direct Investment Fund (RDIF) and Indian generic pharmaceutical company Hetero have agreed to produce more than 100 million doses of Russian-made Sputnik V Covid-19 vaccine per year on Indian soil.
Production is set to start at the beginning of next year, the RDIF, which funded the development of the Russian vaccine, said in a statement.
Continue reading https://on.rt.com/avxw